Single-center, non-randomized, prospective phase II study evaluating the effectiveness of induction chemoimmunotherapy in the combined outcome of locally advanced non-small cell lung disease. Вопр. онкол. [Internet]. 2025 Dec. 30 [cited 2026 Oct. 14];71(6):OF-2369. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/6-25-Single-center